Conference Coverage

Chlamydia infections associated with more than a doubling of ovarian cancer risk


 

FROM THE AACR ANNUAL MEETING

Pelvic inflammatory disease caused by chlamydia appears to significantly increase the risk of ovarian cancer, according to research to be presented at the annual meeting of the American Association for Cancer Research.

The finding, replicated in two large databases, suggests that promptly treating the infection might reduce the lifetime risk of developing ovarian cancer, Britton Trabert, PhD, said during a press briefing held in advance of the meeting.

Dr. Britton Trabert, National Cancer Institute, Bethesda, Md.

Dr. Britton Trabert

“Although these findings need to be replicated, they suggest potential ovarian cancer risk reduction through targeted treatment of chlamydia infections,” said Dr. Trabert, the Earl Stadtman Investigator at the National Cancer Institute.

The study portends both promise and challenge, according to Elaine R. Mardis, PhD, who comoderated the session.

Pages

Recommended Reading

Incidence of HPV-associated cancers on the rise
MDedge Pediatrics
Recommendations for Cancer Moonshot overlook a few issues, YSC says
MDedge Pediatrics
Rise in HPV vaccination spurs CIN drop
MDedge Pediatrics
Parental reasons for HPV nonvaccination are shifting
MDedge Pediatrics
Understanding the human papillomavirus
MDedge Pediatrics
HPV vaccine pioneers win 2017 Lasker-DeBakey Clinical Medical Research Award
MDedge Pediatrics
Missed opportunities abound to give HPV vaccine to adolescent girls
MDedge Pediatrics
International parental attitudes of HPV vaccination have similarities, differences
MDedge Pediatrics
Parents have diverse reasons for refusing HPV vaccine for their child
MDedge Pediatrics
Adolescents with chronic health conditions often undervaccinated
MDedge Pediatrics